Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | COEP | AZN | AMGN | GILD | VRTX |
| Company | Coeptis Therapeutics Hldgs Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.50 | 90.29 | 326.27 | 121.24 | 449.74 |
| High | 14.88 | 91.14 | 328.24 | 122.29 | 452.63 |
| Low | 14.35 | 90.19 | 321.91 | 120.93 | 445.41 |
| Latest | 14.19 | 91.07 | 324.52 | 121.86 | 447.05 |
| Change | -0.31 | +1.21 | -1.49 | +0.50 | -2.47 |
| % Change | -2.14% | +1.35% | -0.46% | +0.41% | -0.55% |
| Volume | 34,148 | 3,838,978 | 1,412,006 | 3,042,961 | 492,922 |
| 20-Day Average Volume | 102,641 | 5,712,571 | 2,816,487 | 6,934,278 | 1,350,719 |
| Previous Close | 14.50 | 89.86 | 326.01 | 121.36 | 449.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.13 | 90.93 | 330.86 | 123.07 | 441.63 |
| 20-Day Raw Stochastic | 9.49% | 45.05% | 32.08% | 32.86% | 62.57% |
| 20-Day Relative Strength | 44.31 | 56.69 | 50.83 | 49.86 | 56.11 |
| Weighted Alpha | +121.38 | +41.42 | +22.42 | +28.49 | +11.18 |
| Today's Opinion | 40% Buy | 96% Buy | 72% Buy | 56% Buy | 72% Buy |
| Previous Opinion | 48% Buy | 88% Buy | 72% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 80% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.64% since 12/11/25 | +0.71% since 12/11/25 | +1.86% since 12/11/25 | -1.28% since 12/11/25 | +0.34% since 12/11/25 |
| Low | 13.61 on 12/16/25 | 89.28 on 12/12/25 | 315.19 on 12/12/25 | 118.17 on 12/16/25 | 444.81 on 12/12/25 |
| High | 16.60 on 12/12/25 | 91.79 on 12/15/25 | 330.04 on 12/17/25 | 123.63 on 12/12/25 | 459.05 on 12/16/25 |
| 1-Month | |||||
| %Chg | -15.59% since 11/18/25 | +1.55% since 11/18/25 | -6.02% since 11/18/25 | -4.36% since 11/18/25 | +2.74% since 11/18/25 |
| Low | 13.61 on 12/16/25 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 418.53 on 11/19/25 |
| High | 21.41 on 11/26/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +14.34% since 09/18/25 | +17.99% since 09/18/25 | +17.21% since 09/18/25 | +7.05% since 09/18/25 | +15.58% since 09/18/25 |
| Low | 12.77 on 09/19/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 21.41 on 11/26/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +85.88% since 06/18/25 | +28.51% since 06/18/25 | +11.62% since 06/18/25 | +12.62% since 06/18/25 | -0.22% since 06/18/25 |
| Low | 6.80 on 06/20/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 21.41 on 11/26/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 77,431 | 278,694,144 | 175,550,208 | 150,568,928 | 114,051,760 |
| Shares Outstanding, K | 5,340 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -10,880,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 240,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -2,740,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -0.53 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.58 on 11/13/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/26/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.99 | 14.94 | 14.50 | 29.72 |